One of the out-patient treatment alternatives for clients in Glen Burnie who are struggling with opioid abuse and addiction is called opioid maintenance therapy. Some centers and doctors are certified to dispense certain meds to opioid addicted individuals, many of which are opioid-based themselves and are habit forming. In low doses the client doesn't experience being high but also doesn't have intense cravings and isn't in opioid withdrawal. Methadone is the first medication tried for this purpose, but there are alternative choices to choose from.
Methadone is an opioid and can be taken at an outpatient medical center certified to dispense the drug, that is taken daily in liquid or pill form. The cost of the drug is approximately one hundred and fifty dolloars a month. Buprenorphine is also an opioid-based drug, and is a pill often taken one day on, one day off. But unlike Methadone which is only be dispensed in well-regulated medical centers, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is around just under $300 /month for the generic of the drug. There is also a version of buprenorphine that contains naloxone, that is a drug that reverses the effects of opioids. A person taking this version of the drug, AKA Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It too is taken daily, and is priced around $450 /month. Naltrexone is an additional med used in opioid maintenance therapy, but unlike the other medications mentioned it is an opiate blocker and isn't an opiate. There is an option to take this medication as a monthly shot, and that is called Vivitrol. As an opioid blocker, it prevents someone from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 a month.
There are 6 Drug and Alcohol Rehab Centers offering this service in Glen Burnie, MD
For All Drug and Alcohol Treatment Centers In Glen Burnie, Click Here.